HighLife Transcatheter Mitral Valve Replacement clinical trials

Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk

This study is testing a new heart valve called HighLife for people with a serious heart condition called mitral regurgitation who can't have traditional open-heart surgery. It aims to see if the new valve is safe and works well.